Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,368 | 31,869 | -569 | -99,317 | -115,870 |
| Depreciation Amortization | -830 | -3,543 | -5,244 | 2,391 | 2,978 |
| Accounts receivable | 1,090 | 329 | 32,554 | -35,196 | 8 |
| Accounts payable and accrued liabilities | 221 | -297 | -1,426 | 68 | -139 |
| Other Working Capital | -68,576 | -126,415 | -62,509 | -30,654 | -22,439 |
| Other Operating Activity | 9,876 | 11,826 | -18,841 | 51,920 | 16,431 |
| Operating Cash Flow | $-75,587 | $-86,231 | $-56,035 | $-110,788 | $-119,031 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -59,524 | 100,010 | -149,834 | 100,000 | 24,098 |
| PPE Investments | -220 | -310 | -840 | -1,740 | -1,609 |
| Investing Cash Flow | $-59,744 | $99,700 | $-150,674 | $98,260 | $22,489 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 110,446 | 7,522 | 30,230 | 648 | 110,213 |
| Financing Cash Flow | $110,446 | $7,522 | $30,230 | $648 | $110,213 |
| Beginning Cash Position | 39,079 | 18,088 | 194,567 | 206,447 | 192,776 |
| End Cash Position | 14,194 | 39,079 | 18,088 | 194,567 | 206,447 |
| Net Cash Flow | $-24,885 | $20,991 | $-176,479 | $-11,880 | $13,671 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,587 | -86,231 | -56,035 | -110,788 | -119,031 |
| Capital Expenditure | -220 | -310 | -840 | -1,740 | -1,609 |
| Free Cash Flow | -75,807 | -86,541 | -56,875 | -112,528 | -120,640 |